Live feed
Filing
SC 13G
SC 13G0000902219-20-000198·Theravance Biopharma, Inc.
Schedule 13G ownership disclosure
THERAVANCE BIOPHARMA INC
Security class unavailable · CUSIP: G8807B106
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,177,537
- Percent of class
- 5.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-20-000198
- Form type
- SC 13G
- Filer
- Theravance Biopharma, Inc.
- CIK
- CIK 1583107
- Filed
- Jan 28, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership